Synthesis of reversed magainin 2 analogs enhanced antibacterial activity

Biological and Pharmaceutical Bulletin

Volumn 20, Issue 3, 1997, Pages 267-270

  Iwahori, Akiyo ^a   Hirota, Yukiko ^a   Sampe, Ruriko ^a   Miyano, Sanae ^a   Numao, Naganori ^a  

^a SAGAMI CHEMICAL RESEARCH CENTER   (Japan)

Author keywords

antibacterial activity; magainin 2; reversed peptide; S. aureus

Indexed keywords

MAGAININ 2; MAGAININ DERIVATIVE;

AMINO ACID SEQUENCE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; CONTROLLED STUDY; ESCHERICHIA COLI; GROWTH INHIBITION; HEMOLYSIS; HUMAN; HUMAN CELL; NONHUMAN; PEPTIDE SYNTHESIS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; STAPHYLOCOCCUS AUREUS;

EID: 0030888402     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.20.267     Document Type: Article

References (22)

1. Zasloff M., Proc. Natl. Acad. Sci. U.S.A., 84, 5449-5453 (1987).
2. Wade D., Boman A., Wahlin B., Drain C. M., Andreu D., Boman H. G., Merrifield R. B., Proc. Natl. Acad. Sci. U.S.A., 87, 4761-4765 (1990).
3. Bessalle R., Kapitkovsky A., Gorea A., Shalit I., Fridkin M., FEBS Lett., 274, 151-155 (1990)
4. Maloy W. L., Kari U. P., Biopolymers, 37, 105-122 (1995).
5. Cuervo J. H., Rodriguez B., Houghten R. A., Peptide Res., 1, 81-86 (1988).
6. Bessalle R., Haas H., Goria A., Shalit I., Fridkin M., Antimicrob. Agents Chemother., 36, 313-317 (1992).
7. Matsuzaki K., Murase O., Fujii N., Miyajima K., Biochemistry, 34, 6521-6526 (1995).
8. Ando N., Ochiai J., Tunemoto D., Hemmi H., Numao N., Pept. Chem., 1989, 209-214 (1990).
9. Chen H.-C., Brown J. H., Morell J. L., Huang C. M., FEBS Lett., 236, 462-466 (1988).
10. Blondelle S. E., Takahashi E., Dinh K. T., Houghten R. A., J. Appl. Bacteriol., 78, 39-46 (1995).
11. Pathak N., Salas-Auvert R., Ruche G., Janna M.-H., McCarthy D., Harrison R. G., Proteins: Struct., Funct., Genet., 22, 182-186 (1995).
12. Mekler L. B., Biofizika, 14, 581-584 (1969).
13. Blalock J. E., Smith E. M., Biochem. Biophys. Res. Commun., 121, 203-207 (1984).
14. Numao N., Kidokoro S., Biol. Pharm. Bull., 16, 1160-1163 (1993).
15. Lie B.-L., Iwahori A., Sampe R., Hirota Y., Tsubota Y., Yoshioka H., Fuchita S., Nakamura N., Saita R., Tunemoto D., Numao N., Biol. Pharm. Bull., 19, 1602-1606 (1996).
16. Maloy W. L., Mac Donald D., Brasseur M., "Proceedings of the 21st European Peptide Symposium," eds. by Giralt E., Andreu D., ESCOM, Leiden, 1991, pp. 743-745.
17. Jacob L., Zasloff M., "Antimicrobial Peptides," (Ciba Foundation Symposium 186), Wiley, Chichester, 1994, pp. 197-223.
18. Maloy W. L., Kari U. P., WO 94/09810 (1994).
19. Hopp T. P., Woods K. R., Proc. Natl. Acad. Sci. U.S.A., 78, 3824-3828 (1981).
20. Schiffer M., Edmundson A. B., Biophys. J., 7, 121-135 (1967).
21. Jacob L., Zasloff M., Williams T., Bedi G., WO 9608270A2 (1996).
22. Tytler E. M., Anantharamaiah G. M., Walker D. E., Mishra V. K., Palgunachari M. N., Segrest J. P., Biochemistry, 34, 4393-4401 (1995).